Готові списки джерел за темами / Pharmacist and patient

Добірка наукової літератури з теми "Pharmacist and patient"

Автор: Grafiati
Опубліковано: 4 червня 2021
Оновлено: 26 лютого 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Pharmacist and patient".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Статті в журналах з теми "Pharmacist and patient":

1

Winslade, Nancy, and Robyn Tamblyn. "Determinants of community pharmacists’ quality of care: a population-based cohort study using pharmacy administrative claims data." BMJ Open 7, no. 9 (September 2017): e015877. http://dx.doi.org/10.1136/bmjopen-2017-015877.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
ObjectiveTo determine if a prototype pharmacists’ services evaluation programme that uses linked community pharmacy claims and health administrative data to measure pharmacists’ performance can be used to identify characteristics of pharmacies providing higher quality of care.DesignPopulation-based cohort study using community pharmacy claims from 1 November 2009 to 30 June 2010.SettingAll community pharmacies in Quebec, Canada.Participants1742 pharmacies dispensing 8 655 348 antihypertensive prescriptions to 760 700 patients.Primary outcome measurePatient adherence to antihypertensive medications.PredictorsPharmacy level: dispensing workload, volume of pharmacist-provided professional services (eg, refusals to dispense, pharmacotherapy recommendations), pharmacy location, banner/chain, pharmacist overlap and within-pharmacy continuity of care. Patient level: sex, age, income, patient prescription cost, new/chronic therapy, single/multiple antihypertensive medications, single/multiple prescribers and single/multiple dispensing pharmacies. Dispensing level: prescription duration, time of day dispensed and antihypertensive class. Multivariate alternating logistic regression estimated predictors of the primary outcome, accounting for patient and pharmacy clustering.Results9.2% of dispensings of antihypertensive medications were provided to non-adherent patients. Male sex, decreasing age, new treatment, multiple prescribers and multiple dispensing pharmacies were risk factors for increased non-adherence. Pharmacies that provided more professional services were less likely to dispense to non-adherent hypertensive patients (OR: 0.60; 95% CI: 0.57 to 0.62) as were those with better scores on the Within-Pharmacy Continuity of Care Index. Neither increased pharmacists’ services for improving antihypertensive adherence per se nor increased pharmacist overlap impacted the odds of non-adherence. However, pharmacist overlap was strongly correlated with dispensing workload. There was significant unexplained variability among pharmacies belonging to different banners and chains.ConclusionsPharmacy administrative claims data can be used to calculate pharmacy-level characteristics associated with improved quality of care. This study supports the importance of pharmacist’s professional services and continuity of pharmacist’s care.
2

Berry, Melanie, Amy Gustafson, Maya Wai, and Alex J. Luli. "Evaluation of an Outpatient Pharmacist Consult Service at a Large Academic Medical Center." INNOVATIONS in pharmacy 12, no. 2 (April 28, 2021): 13. http://dx.doi.org/10.24926/iip.v12i2.3238.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Objective: To evaluate a novel outpatient pharmacist consult service in a large academic medical center. Setting: Four outpatient pharmacies that are part of a large academic medical center Methods: An outpatient pharmacist consult order was created and embedded in the electronic medical record (EMR). Medical center providers utilized this consult order when identifying patients in need of specific services provided by outpatient pharmacists. Descriptive data about each individual consult was collected including number completed, type of service, and duration. Rate of accepted pharmacy recommendations and patient cost savings were also evaluated. A survey was administered at the completion of the study period to assess provider and pharmacist satisfaction with the service. Patient demographic information was collected for those who had a documented completed consult. Results: A total of 193 consults were completed: 137 immunizations, 37 care affordability, 15 education, 3 polypharmacy and 1 OTC recommendation. 89% of completed consults took pharmacists 20 minutes or less to complete. Of completed care affordability consults (n=31), 55% of patients saved between $100 - $500 per medication fill. Of providers who completed a survey and utilized the service (n=12), 83.3% were extremely satisfied and 16.7% were satisfied with it. The provider acceptance rate of pharmacist’s recommendations was 74%. Conclusion: Implementation of an outpatient pharmacist consult service provided an alternative method for the utilization of pharmacist provided MTM services in outpatient pharmacies at a large academic medical center. The service was well received by both providers and pharmacists.
3

Asiya, Asiya Saif, Maria Gul, Tangina Malik Tangina, and Mubashra Gul. "EVALUATION OF COMMUNITY PHARMACIST INTERVENTIONS IN DIABETES AND BLOOD PRESSURE MANAGEMENT." International Journal of Pharmacy & Integrated Health Sciences 3, no. 2 (October 24, 2022): 52–59. http://dx.doi.org/10.56536/ijpihs.v3i2.28.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: The pharmacist community played a significant role in serving the nation for many years. The total number of registered pharmacists by the provincial pharmacy council is 23029. The role of pharmacists and their services is unrecognized by society. Aims: The intention of this clinical project is to create awareness among the population regarding the pharmacist's role in improving the health of the patients and disease management. The aim is to highlight the importance of pharmacists among patients regarding their medication therapy and lifestyle modification to provide clear evidence of health gain. Methodology: It is a non-experimental based questionnaire study which is performed in community pharmacy and medical stores of Lahore, Islamabad, Gujranwala and Sargodha. Most of the people in Pakistan visit medical stores for the grant of medication without pharmacist advice in rural areas of Punjab Pakistan. But in big cities such as Lahore, Islamabad people visit pharmacies for grant of their medication and in some pharmacies pharmacist counsel the patient regarding their medication and visit a pharmacist are more satisfied and feel improvement in their condition. Results: Patients were divided in two group, one who visited medical store and other who went to pharmacy. We are interested in patients who are visiting the pharmacy and getting the various type of benefits from the presence of pharmacist. Conclusion Diabetes and hypertension are two major chronic diseases and spread widely across the world including Pakistan. In the management of diabetes and hypertension pharmacist interventions are beneficial and literature study provide evidence of it. People who visit a pharmacy also get economic benefit as pharmacist also offer alternatives which costs lesser.
4

Soubolsky, Amy, and Katelyn Halpape. "The Time is Now for Mental Health Care: Evaluating the Impact of a Clinical Pharmacist on an Acute Mental Health Unit." Canadian Journal of Hospital Pharmacy 75, no. 4 (October 3, 2022): 317–25. http://dx.doi.org/10.4212/cjhp.3210.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: Clinical pharmacists have a significant role in optimizing pharmacotherapy for patients admitted to acute care settings. Patients with mental health disorders are especially vulnerable to polypharmacy, adverse drug effects, medication nonadherence, and misconceptions about medication use. The Royal University Hospital in Saskatoon, Saskatchewan, currently lacks resources to provide optimal clinical pharmacy coverage for mental health inpatients. Objectives: To determine the optimal clinical role for a pharmacist providing specialized care to mental health inpatients and to evaluate the potential impact of the pharmacist on medication use and patient care. Methods: A pharmacist with 5 years of mental health–related pharmacy practice experience was temporarily assigned to the Mental Health Short Stay Unit as a practical component of a Master’s program in pharmacy. Clinical activities to be completed by the pharmacist were defined on the basis of available evidence, existing performance and quality assurance indicators, and prior experience. The pharmacist’s activities and recommendations during each shift were tracked and reported. Results: The pharmacist saw 94 patients over a total of 88 hours. The pharmacist made a total of 61 recommendations, of which 55 (90%) were accepted by the psychiatrist, and initiated 42 medication changes. Forty-one patients (44%) received a thorough medication assessment, and individualized, often specialized, education was provided to patients 39 times. The pharmacist was consulted by the psychiatrist 19 times. Conclusions: Pharmacists have an important role in medication management and patient education for psychiatric inpatients, and the health care team values pharmacists’ unique expertise. Additional resources dedicated to defining and expanding clinical pharmacy services on inpatient psychiatry units could further optimize patient care. RÉSUMÉ Contexte : Les pharmaciens cliniciens jouent un rôle important dans l’optimisation de la pharmacothérapie pour les patients admis en milieu de soins aigus. Les patients souffrant de troubles de la santé mentale sont particulièrement vulnérables à la polypharmacie, aux effets indésirables des médicaments, au non-respect de la médication et aux idées fausses circulant sur leur utilisation. L’hôpital Royal University, à Saskatoon (Saskatchewan), manque actuellement de ressources pour offrir une couverture pharmaceutique clinique optimale aux patients hospitalisés en santé mentale. Objectifs : Déterminer le rôle clinique optimal du pharmacien fournissant des soins spécialisés aux patients hospitalisés en santé mentale et évaluer son impact potentiel sur l’utilisation des médicaments et les soins aux patients. Méthodes : Un pharmacien ayant 5 ans d’expérience dans la pratique de la pharmacie liée à la santé mentale a été temporairement affecté à l’unité de séjours de courte durée en santé mentale dans le cadre de la composante pratique d’un programme de maîtrise en pharmacie. Les activités cliniques qu’il devait réaliser ont été définies sur la base des données probantes à disposition, des indicateurs de performance et d’assurance de la qualité existants, ainsi que sur la base de son expérience antérieure. Les activités et les recommandations du pharmacien au cours de chaque quart de travail étaient suivies et signalées. Résultats : Le pharmacien a visité 94 patients sur un total de 88 heures. Au total, il a fait 61 recommandations, dont 55 (90 %) ont été acceptées par le psychiatre, et il a amorcé 42 changements de traitement. Quarante et un patients (44 %) ont reçu une évaluation approfondie concernant le traitement, et des patients ont reçu une explication individualisée, souvent spécialisée, 39 fois. Le psychiatre a consulté le pharmacien 19 fois. Conclusions : Les pharmaciens jouent un rôle important dans la gestion des médicaments et l’éducation des patients hospitalisés en psychiatrie, et l’équipe de soins de santé apprécie leur expertise unique. Des ressources supplémentaires consacrées à la définition et à l’élargissement des services de pharmacie clinique dans les unités de psychiatrie pour patients hospitalisés pourraient optimiser davantage les soins aux patients.
5

Mikhael, Ehab Mudher, and Haydar F. Al-Tukmagi. "The compliance of Iraqi pharmacists with ethical principles in applying the pharmaceutical care for diabetic patients." Clinical Ethics 11, no. 4 (July 18, 2016): 159–65. http://dx.doi.org/10.1177/1477750916657659.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Pharmacists play a central role in caring of diabetic patients. During patient-centered care, important ethical issues and conflicts may arise, which makes ethical skills for pharmacist important toward conflict-resolution so this study aimed to assess compliance of Iraqi pharmacists with ethical principles while providing their care to diabetic patients. A cross sectional study by a validated questionnaire format was given to a convenient sample of 95 community pharmacists in Baghdad—Iraq. The questionnaire assesses the ethical practices of each pharmacist by using indirect questions through a simulated case which is commonly encountered in private pharmacies in Iraq. Most participated pharmacists failed to respect patient autonomy and they are not encouraging their patients to participate in decision making about their treatment. Participated pharmacists also failed in applying ethical principle of veracity during educating the patient about serious drug side effects. Furthermore most pharmacists had financial conflict of interests that undermine the pharmacist ability to fulfill the primary professional and ethical obligation to ensure patient's beneficence, justice and autonomy. Meanwhile most participated pharmacist may be good in maintaining their professional competence, yet the majority failed to develop their competence by keeping their knowledge up to-dated. In conclusion pharmacists failed to apply ethical principles during their usual care for diabetic patients.
6

Lorensia, Amelia, and Jessica Nathania. "STUDI KELENGKAPAN PENJELASAN INFORMASI CARA PENGGUNAAN CONTROLLERMETERED-DOSE INHALER (MDI) YANG MENGANDUNG KORTIKOSTEROID SEBAGAI TERAPI ASMA DI APOTEK KABUPATEN TUBAN." Jurnal Ilmiah Manuntung 3, no. 1 (June 21, 2017): 14. http://dx.doi.org/10.51352/jim.v3i1.86.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This experiment centred in metered dose inhaler (MDI) device which used routinely by asthma patient as controller therapy. MDI used ask patient’s skill more when using their medication. MDI technique informnation provided by pharmachist are important to achive optimal medication in asthma therapy. By a non experimental study, mysterious patient collect MDI technique gived by pharmacist in Tuban pharmacy using observacional and cross sectional method. Information about MDI technique comprehensive collected by two ratter as mysterious patient which assessed with checklist that got measseured by kappa to know ratter aggrement percentage. The result showed from a total sampling under 41 pharmachist which represent each 41 pharmacy in Tuban, by purposive sampling Pharmacists as pharmaceutical personnel responsible for information services at pharmacies, including information on how to use MDI. Most of the apothecary's ability level in providing information is still lacking, then continued with adequate technique, and optimal technique in providing complete information of MDI use for asthma patient. Pharmacists know how to use MDI and no pharmacist is unexpected or not familiar with MDI as an asthma therapy. Pharmacists in Tuban district have a tendency to inform only four stages of the nine stages of MDI use from Osman et al (2012), ie at the 1st, 3rd, 5th, and 6th stages of MDI use
7

Olufemi-Yusuf, Damilola, Sophie Gabriel, Tatiana Makhinova, and Lisa Guirguis. "“Being in Control of My Asthma Myself” Patient Experience of Asthma Management: A Qualitative Interpretive Description." Pharmacy 6, no. 4 (November 15, 2018): 121. http://dx.doi.org/10.3390/pharmacy6040121.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Asthma control can be achieved with effective and safe medication use; however, many patients are not controlled. Patients’ perceptions of asthma, asthma treatment, and pharmacist roles can impact patient outcomes. The purpose of this study was to explore patients’ experiences and patient–pharmacist relationships in asthma care. Qualitative Interpretive Description method guided the study. Semi-structured individual interviews were conducted with 11 patients recruited from personal contacts, pharmacies, and asthma clinics. Categories and themes were identified using inductive constant comparison. Themes indicated patients had a personalized common sense approach to asthma management, “go-to” health care provider, and prioritized patient–pharmacist relationships. Patients described their illness experiences and asthma control based on personal markers similar to the common sense model of self-regulation. Patients chose a family physician, asthma specialist, respiratory therapist, or pharmacist as an expert resource for asthma management. Patient perceived pharmacists’ roles as information provider, adviser, or care provider. Pharmacists who develop a collaborative relationship with their asthma patients are better positioned to provide tailored education and self-management support. Inviting patients to share their perspective could increase patient engagement and uptake of personalised asthma action plans to achieve asthma control.
8

Melo, Angelita C., Guilherme M. Trindade, Alessandra R. Freitas, Karina A. Resende, and Tarcísio J. Palhano. "Community pharmacies and pharmacists in Brazil: A missed opportunity." Pharmacy Practice 19, no. 2 (June 22, 2021): 2467. http://dx.doi.org/10.18549/pharmpract.2021.2.2467.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The Brazilian National Health System (BR-NHS) is one of the largest public health systems in the world. In 2019 Brazil had 114,352 community pharmacies (76.8% private owned), that represent the first point of access to healthcare in Brazil due to their wide distribution. Unfortunately, from the government's point of view, the main expected activity of private and public community pharmacies is related to dispensing medicines and other health products. Public community pharmacies can be part of a healthcare center or be in a separate location, sometimes without the presence of a pharmacist. Pharmacists working in these separated locations do not have access to patients’ medical records, and they have difficulty in accessing other members of the patient care team. Pharmacists working in public pharmacies located in healthcare centers may have access to patients’ medical records, but pharmacy activities are frequently under other professional’s supervision (e.g., nurses). Private pharmacies are usually open 24/7 with the presence of a pharmacist for 8 hours on business days. Private community pharmacies have a very limited integration in the BR-NHS and pharmacists are the third largest healthcare workforce in Brazil with more than 221,000 registered in the Brazilian Federal Pharmacist Association [CFF - Conselho Federal de Farmácia]. A University degree in pharmacy is the only requirement to entry into the profession, without any proficiency exam for maintenance or career progression. The Brazilian pharmacist's annual income is ranked as the 2nd better-paid profession with an annual average income of € 5502.37 (in 2020). Description of clinical activities for pharmacies by the CFF increased in the recent years, however there is still a long way to effectively implement them into practice.
9

Mohiuddin, Abdul. "Patient Care Management (Handbook for Hospital and Community Pharmacists)." Clinical Research Notes 1, no. 2 (June 10, 2020): 01–14. http://dx.doi.org/10.31579/2690-8816/010.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Most people on the outside of the health care profession are not familiar with this new role of the pharmacist. The general public has created a stereotypical pharmacist's picture as being a person who stands behind a counter, dispenses medicine with some instructions to the respective consumer. Pharmacy practice has changed substantially in recent years. Today’s pharmacists have unique training and expertise in the appropriate use of medications and provide a wide array of patient care services in many different practice settings. As doctors are busy with the diagnosis and treatment of patients, the pharmacist can assist them by selecting the most appropriate drug for a patient. Interventions by the pharmacists have always been considered as a valuable input by the health care community in the patient care process by reducing the medication errors, rationalizing the therapy and reducing the cost of therapy. The development and approval of the Pharmacists’ Patient Care Process by the Joint Commission of Pharmacy Practitioners and incorporation of the Process into the 2016 Accreditation Council for Pharmacy Education Standards has the potential to lead to important changes in the practice of pharmacy, and to the enhanced acknowledgment, acceptance, and reimbursement for pharmacy and pharmacist services. As an author, it is my heartiest believe that the book will adjoin significant apprehension to future pharmacists in patient care as most of the portion created from recently published articles focusing pharmacists in patient care settings.
10

Lau, Kimberly M., Ila M. Saunders, Assuntina G. Sacco, and Linda C. Barnachea. "Evaluation of pharmacist interventions in a head and neck medical oncology clinic." Journal of Oncology Pharmacy Practice 26, no. 6 (January 14, 2020): 1390–96. http://dx.doi.org/10.1177/1078155219897129.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Introduction Head and neck cancers (HNC) are a complex and heterogeneous group of cancers, often necessitating a multidisciplinary approach across the care continuum. Oncology pharmacists are uniquely qualified to play a vital role on a multidisciplinary team and provide specialized care to optimize medication therapy. Methods This was a retrospective chart review evaluating the role of a board-certified oncology pharmacist in the head and neck oncology clinic at an academic, comprehensive cancer center from April 2017 through March 2018. The primary objective of the study was to describe the types of interventions made by the oncology pharmacists. Secondary objectives included quantifying time spent on patient education and number of prescriptions sent to pharmacies. Results The pharmacist had 873 encounters with 151 patients, resulting in 2080 interventions. Approximately 57% of the interventions were performed in the clinic. Patient education (58%), facilitation of new prescriptions or refill requests (49.9%), and supportive care management (32.6%) were the most frequent interventions. The oncology pharmacist spent 154.1 h on patient education and sent 811 prescriptions to pharmacies, with 63.6% of prescriptions sent to the institution’s cancer center pharmacy. Conclusion The incorporation of an oncology pharmacist in the HNC team optimized patient care through comprehensive and timely interventions across the care continuum. Our study is the first to highlight the vital role oncology pharmacists have in improving the overall quality of care of HNC patients. Future directions include exploring the impact of oncology pharmacist interventions on select Quality Oncology Practice Initiative measures by the American Society of Clinical Oncology.
Більше джерел
Також вас можуть зацікавити розширені добірки на тему "Pharmacist and patient" для конкретних типів джерел:
Статті в журналах Дисертації Книги

Дисертації з теми "Pharmacist and patient":

1

Sinnott, Patricia A. "Pharmacists' illness experience and the pharmacist-patient relationship." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp01/MQ29338.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Grainger-Rousseau, T. "Contributions of the community pharmacist to patient care." Thesis, Queen's University Belfast, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.317506.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Watman, Geoffrey P. "Pharmacist monitoring of patient health in the community." Thesis, Aston University, 1996. http://publications.aston.ac.uk/10935/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This research has explored the potential role of the community pharmacist in health promotion in the pharmacy, and at general medical practices. The feasibility of monitoring patients' health status in the community was evaluated by intervention to assess and alter cardiovascular risk factors. 68, hypertensive patients, monitored at one surgery, had a change in mean systolic blood pressure from 158.28 to 146.55 mmHg, a reduction of 7.4%, and a change in mean diastolic bood pressure from 90.91 to 84.85 mmHg, a reduction of 6.7%. 120 patients, from a cohort of 449 at the major practice, with an initial serum total cholesterol of 6.0+mmol/L, experienced a change in mean value from 6.79 to 6.05 mmol/L, equivalent to a reduction of 10.9%. 86% of this patient cohort showed a decrease in cholesterol concentration. Patients, placed in a high risk category according to their coronary rank score, assessed at the first health screening, showed a consistent and significant improvement in coronary score throughout the study period of two years. High risk and intermediate risk patients showed improvements in coronary score of 52% and 14% respectively. Patients in the low risk group maintained their good coronary score. In some cases, a patient's improvement was effected in liaison with the GP, after a change or addition of medication and/or dosage. Pharmacist intervention consisted of advice on diet and lifestyle and adherence to medication regimes. It was concluded that a pharmacist can facilitate a health screening programme in the primary care setting, and provide enhanced continuity of care for the patient.
4

Lee, Stephanie, Kristin Peterson, Matthew Noble, and Richard Herrier. "Survey on Patient Safety and Pharmacist Working Conditions." The University of Arizona, 2015. http://hdl.handle.net/10150/614139.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Class of 2015 Abstract
Objectives: To assess pharmacists’ perspectives on patient safety in relation to their working conditions. Methods: The survey was sent to 1000 pharmacists within Arizona. Results for the item evaluating pharmacists’ level of agreement with the statement regarding their employers providing a work environment optimized for safe patient care were compared to those from the Oregon Working Conditions Survey using Mann Whitney U. Mann Whitney U was also used to compare agreement between Arizona pharmacists who filled less than and more than 200 prescriptions per shift, and between Arizona community and hospital pharmacists. Chi-squared test was used to compare community pharmacists in Arizona and Oregon. A priori alpha level was 0.05 for all statistical tests. Results: Arizona pharmacists were significantly more likely than Oregon pharmacists to agree with the statement that their employer provided a work environment conducive to patient safety (p < 0.001). Arizona pharmacists who filled less than 200 prescriptions per shift agreed significantly more than those who filled more than 200 prescriptions per shift (p < 0.001). Hospital pharmacists were significantly more likely to agree with the patient safety statement than community pharmacists (p < 0.001). Conclusions: The pharmaceutical climate may play a role in the difference between Oregon and Arizona. With a lower percentage of chain/mass merchandiser community pharmacy respondents in Arizona, the overall agreement with the patient safety statement could have been influenced by practice type. Regardless, higher prescription volume still remains as a factor that can have potentially deleterious effects on optimization of patient safety.
5

Gade, Carmin Jane. "An exploration of the pharmacist-patient communicative relationship." Columbus, Ohio : Ohio State University, 2003. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1061259087.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Thesis (Ph. D.)--Ohio State University, 2003.
Title from first page of PDF file. Document formatted into pages; contains xii, 123 p.; also includes graphics (some col.). Includes abstract and vita. Advisor: Donald J. Cigala, Dept. of Communication. Includes bibliographical references (p. 117-123).
6

Garcia, Miguel. "Descriptive Study of Student Pharmacist Perceptions of Patient Health Literacy and Self Assessment of Student Pharmacist Communication Techniques." The University of Arizona, 2012. http://hdl.handle.net/10150/623610.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Class of 2012 Abstract
Specific Aims: The objective of this study is to first assess whether student pharmacist interns feel they can gauge patient health literacy levels with confidence, second to assess which methods are used most commonly in practice by student pharmacists to assess patient health literacy, and third to determine what techniques student pharmacist interns most often employ to communicate more effectively to patients with low health literacy. Methods: The questionnaire consisted of questions about demographics, and knowledge/experiential based questions. Key questions were: How well do you feel you are able to assess patient health literacy? How often do you use the following techniques to assess patient health literacy? (Observe contextual clues, Observe patient word pronunciation, Observe patient willingness to talk, Assess by demographics) When counseling low health literacy patients, how often do you use the following communication techniques? (Speak slowly, Give extra written material, Repeat information, Ask patient to repeat information, Ask if patient understands English, Avoid complicated medical terms). The answers to these questions are measured on a likert scale. Data from the questionnaire was analyzed using one sample t tests and paired t tests. Main Results: Regarding the first primary objective, on a scale of 1 to 5, with confidence measured 3 or greater and no confidence measured 2 or less, student intern pharmacists are statistically significantly confident in their ability to gauge patient health literacy (p< 0.001). There is no statistically significant difference in confidence in ability to gauge patient health literacy between males and females. The method student pharmacist interns used for assessing patient health literacy with the highest average use was observing patient willingness to talk (3.65 +/- 1.01) followed by observing patient word pronunciation (3.57 +/- 0.97), assessing patient demographics (race, age, ability to pay, culture, gender) (3.23 +/- 1.16) and observing contextual clues (patients identify pills by color, asks to be read to, etc) (3.04 +/- 1.04). There was no statistically significant difference between observing patient willingness to talk versus observing patient word pronunciation (p=0.55). There is a statistically significant difference between observing patient willingness to talk versus assessing patient demographics (p=0.011). The technique for improving communication with patients with low health literacy with the highest average use was avoiding complicated medical terms (3.97 +/- 0.95) followed by speaking slowly (3.91 +/- 0.89), repeating information (3.85 +/- 0.73), giving extra written material (3.02 +/- 1.36), asking patients if they understand English (2.85 +/- 1.21) and asking patients to repeat information. (2.39 +/- 1.02). There is a statistically significant difference between avoiding complicated medical terms and giving out extra written material (p<0.001) and speaking slowly and giving out extra written material (p<0.001). Conclusions: We conclude that students pharmacists working as interns are quite confident in their ability to assess patient health literacy, that observing patient willingness to talk is be the most commonly used method to assess patient health literacy, and that avoiding complicated medical terms is be the most commonly used technique student pharmacist interns use to communicate more effectively with patients who have low health literacy.
7

Jarernsiripornkul, Narumol. "Pharmacist input into patients' self-reporting of adverse drug reactions." Thesis, Robert Gordon University, 1999. http://hdl.handle.net/10059/2717.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Adverse drug reactions (ADRs) are common and should be reported to the CSM, particularly for newly marketed drugs. There is under-reporting of ADRs by doctors. Involving the patient in self-reporting, particularly when initiated by pharmacists is feasible and could help to improve reporting rates. This study investigated a comprehensive checklist questionnaire listed symptoms in all body systems to facilitate patient self-reporting using both established and new 'black triangle' centrally-acting drugs. Symptoms reported were compared to their documentation in medical notes and for new drugs to reports from other sources. A novel classification system for ADRs was developed to take account of the minimal data available and used to evaluate the potential accuracy of symptom attribution by patients. An external comparison of a sample of symptom classifications by an ADR expert was also obtained. The questionnaire was sent to 464 patients prescribed carbamazepine, sodium valproate, trazodone, doxepin and co-proxamol from three participating medical practices in a pilot study. Subsequently, it was sent to all patients (n=2307) prescribed tramadol, fentanyl patch, venlafaxine, nefazodone, citalopram, moclobemide, gabapentin, lamotrigine and topiramate from 79 participating medical practices in Grampian during January-March 1997. The overall response rates were 44.6% (n=207) for the pilot study and 36.3% (n=837) for the main study. The most frequently reported symptoms were: drowsiness for carbamazepine, unusual tiredness for sodium valproate, constipation for co-proxamol, dry mouth for trazodone, doxepin, tramadol, venlafaxine, nefazodone, moclobemide and citalopram, weight gain for gabapentin, loss of memory for lamotrigine, weight loss for topiramate and constipation for fentanyl patch. Overall only 22.4% (522/2330) of symptoms reported by patients were recorded by GPs in the 310 medical notes accessed. In general, common symptoms were reported more frequently by patients than in CSM reports and PEM data. Patients tended to report minor and known ADRs which bothered them, while CSM and PEM reports received were of more severe ADRs. Respondents were more likely to report symptoms (6040/8630,70%) potentially caused by the study drugs than those not to be caused by the study drugs. Moderate agreement (Kappa = 0.4-0.5) was found between expert and researcher classifications of symptom causality. It is suggested that interpretation by pharmacists of patient self-reporting using the checklist questionnaire could result in much higher ADR reporting rates, in particular for new drugs.
8

Ioffe, Viktoriya. "Patient Satisfaction with Pharmacist Intervention, Consultation, and Services Provided by Pharmacist for Hormone Replacement Therapy at Don’s Compounding Pharmacy." The University of Arizona, 2007. http://hdl.handle.net/10150/624401.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Class of 2007 Abstract
Objectives: To assess the level of women’s satisfaction with pharmacist intervention, consultation, and services provided in HRT in order to analyze, and improve patient care at Don’s Compounding Pharmacy, Reno, NV. Methods: This descriptive study was done by offering to complete the 14-th questions survey to 300 female patients who had completed their HRT consultation at Don’s Compounding pharmacy. The data collection was performed from September, 19 2006 till January, 15 2007. The returned surveys were then organized and analyzed using Microsoft Excel. Results: Of the 300 surveys offered to complete, 40 were filled out (a response rate of 13.3%). 90% of the participants were customers of the pharmacy up to 5 years. 65% of the participants have used HRT for up to 5 years. The Biest in combination with progesterone or alone was the most prescribed medication (27.5% and 20% respectively). The most often prescribed dosage form was the cream (47.5%). 57.5% of participants answered that a pharmacist has spent 0-5 minutes in average per consultation. All sources of information (pharmacist, physician, mass media, and family/friends) were helpful or very helpful; a pharmacist had the first place among all of them. However, the difference in helpfulness was not statistically significant (benefits and adverse event: P=0.26 and 0.42 respectively). The total satisfaction score with pharmacist’s intervention, education and services was 3.4 (agree, very agree). Conclusions: The majority of the patients from this local pharmacy were satisfied with services provided, and the education received. Despite this fact, time to spend with patients and the education regarding adverse drug events should be improved. The overall patient satisfaction was above the average. Future studies may be considered in studying improvement of the pharmacist’s services and interventions.
9

Beechey, Riley Tegan Anne. "Pharmacist Utilization of Opioid Misuse and Abuse Interventions: Acceptability Among Pharmacists and Patients in Detox." Kent State University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=kent1499974262218499.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Venter, Ignatius Johannes Erhardt. "The role of the community pharmacist in cardiovascular disease management." Thesis, Nelson Mandela Metropolitan University, 2007. http://hdl.handle.net/10948/652.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Cardiovascular disease contributes to mortality and morbidity statistics worldwide and in South Africa. The current focus in health care revolves around activities aimed at preventing the development of cardiovascular disease, rather than the treatment of disease. The identification of risk factors that can predispose a patient to the development of cardiovascular disease is an essential component of any cardiovascular disease management programme. It is necessary that in the management of these risk factors, they are not considered to be isolated, but inter-related. Through the provision of point-of-care cardiovascular risk screening and monitoring services as well as disease-related counselling, the community pharmacist, as a readily accessible source of healthcare, can play an essential role in the cardiovascular disease management process. The aim of this study was to describe the nature of the services provided by community pharmacists with respect to cardiovascular risk and disease management in the Nelson Mandela Metropole. The research design was a non-experimental, descriptive study using a crosssectional survey method. Data was obtained through the utilisation of a questionnaire. The questionnaire consisted of three sections and was administered to community pharmacies in the Nelson Mandela Metropole, that provided cardiovascular point-of-care screening services. The community pharmacists correctly identified cardiovascular risk factors such as obesity (76.6 percent; 36, n=47) and smoking (27.7 percent; 13, n=47). Other cardiovascular risk factors such as abdominal obesity (4.2 percent; 2, n=47), gender (2.1 percent; 1, n=47) and family history (4.2 percent; 2, n=47) were largely ignored by the pharmacists. Point-of-care testing services were readily available in the pharmacies, with all of the pharmacies providing blood glucose and blood pressure measurements. Blood cholesterol measurements were only provided in 87.8 percent (36, n=41) of the pharmacies. The services were generally provided in a clinic facility, with 90.2 percent (37, n=41) of the pharmacies having a clinic facility available. Pharmacists were involved in the provision of point-of-care services, with 85.4 percent (35, n=41) of the pharmacies indicating that the pharmacists participated. Pharmacists readily provided counselling prior (70.7 percent; 29, n=41) to and after (80.5 percent; 33, n=41) the conduction of the screening services on areas such as lifestyle modification and treatment options. Only 15 percent (7, n=47) of the pharmacists indicated that they were aware of Cardiovascular Risk Calculator Tools and none of the pharmacists indicated that they had utilised such a tool. Pharmacists recommended frequent monitoring (60.5 percent; 26, n=43) and lifestyle modification (67.4 percent; 29, n=43) to patients, if the result of their screening service was within normal limits. However, the majority of the pharmacists indicated that they would refer patients, if the results obtained were out of the normal range. Conclusions based on the findings indicated that the pharmacists are readily providing cardiovascular risk screening services. The pharmacists were also able to identify the presence of any risk factors that can lead to the development of cardiovascular disease in the patients. However, active pharmaceutical involvement in further cardiovascular disease monitoring seemed to be lacking. Recommendations were made on areas such as reimbursement for pharmaceutical care services, increased utilisation of support staff and Continuing Professional Development events that could assist in improving the role of the community pharmacist in cardiovascular disease management.
Більше джерел

Книги з теми "Pharmacist and patient":

1

Sinnott, Patricia A. Pharmacists' illness experience and the pharmacist-patient relationship. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Blumenthal, Dale. Pharmacists help solve medication mysteries. [Rockville, Md: Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Maudlin, Pangilinan Joanna, Waddell J. Aubrey, and American Pharmacists Association, eds. On being a pharmacist: True stories by pharmacists. Washington, DC: American Pharmacists Association, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Pangilinan, Joanna Maudlin. On being a pharmacist: True stories by pharmacists. Washington, D.C: American Pharmacists Association, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Rantucci, Melanie J. Pharmacists talking with patients: A guide to patient counseling. Baltimore: Williams & Wilkins, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Rantucci, Melanie J. Pharmacists talking with patients: A guide to patient counseling. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Rantucci, Melanie J. Talking with patients: A pharmacist's guide to patient counselling. Kingston, Ont: Weathervane Books, 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Greco, Rafelina. A needs assessment study of HIV-positive patients with respect of pharmacy services. [Toronto, Ont: s.n.], 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Berger, Bruce A. Communication skills for pharmacists: Building relationships, improving patient care. 2nd ed. Washington, D.C: American Pharmacists Association, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Berger, Bruce A. Communication skills for pharmacists: Building relationships, improving patient care. 3rd ed. Washington, DC: American Pharmacists Association, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Pharmacist and patient":

1

Hanh, Jacky, Philip Hazell, and Isabelle Feijo. "The Pharmacist and Pharmacotherapy." In Longer-Term Psychiatric Inpatient Care for Adolescents, 153–60. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-1950-3_17.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
AbstractClinical pharmacy services aim to optimise health outcomes and improve patient safety throughout all steps of the medicines management pathway, by ensuring the quality use of medicines and minimising medication-related problems. The role of the pharmacist includes gathering and documenting medication histories, performing medication reconciliation and undertaking clinical medication reviews. These services support collaborative approaches between patients, carers and the multidisciplinary team to develop patient-centred medication management plans. The practice of pharmacotherapy at the Walker Unit shares features in common with prescribing in acute child and adolescent mental health inpatient units, but there are some differences. This chapter will in particular seek to highlight the characteristics of pharmacotherapy that are distinct to longer stay intensive psychiatric care.
2

Cavaco, Afonso. "Pharmaceutical Care and Patient Counseling." In The Pharmacist Guide to Implementing Pharmaceutical Care, 33–40. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Martin, Marcus L., DeVanté J. Cunningham, and Emmanuel Agyemang-Dua. "Pharmacist to Physician: “Are You Really a Doctor?”." In Diversity and Inclusion in Quality Patient Care, 465–69. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92762-6_67.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Franky and Brian K. Fung. "The Pharmacist’s View: Patient-Centered Care Through the Lens of a Pharmacist." In Health Informatics, 69–77. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-91237-6_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Liekens, Sophie, and Veerle Foulon. "Pharmaceutical Care and the Role of the Patient." In The Pharmacist Guide to Implementing Pharmaceutical Care, 25–31. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Volland, Dirk, Klaus Korak, David Brückner, and Tobias Kowatsch. "Towards Design Principles for Pharmacist-Patient Health Information Systems." In Design Science at the Intersection of Physical and Virtual Design, 519–26. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-38827-9_45.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Santoso, Setiyo Budi, Nurkholis Ashari, and Ika Mulyono Putri Wibowo. "Is the Therapeutic Adherence of Hypertensive Patients Closely Related to the Pharmacist-Patient Communication?" In Proceedings of the 3rd Borobudur International Symposium on Humanities and Social Science 2021 (BIS-HSS 2021), 34–39. Paris: Atlantis Press SARL, 2023. http://dx.doi.org/10.2991/978-2-494069-49-7_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Volland, Dirk, Klaus Korak, and Tobias Kowatsch. "Emerging Patterns of Communication in a Pharmacist-Patient Health Information System." In Advancing the Impact of Design Science: Moving from Theory to Practice, 378–82. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06701-8_29.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Debrah, Justice Kofi, Diogo Guedes Vidal, and Maria Alzira Pimenta Dinis. "Sustainable Pharmaceutical Waste Management: Pharmacist and Patient Perception in Ghanaian Hospitals." In Handbook of Sustainability Science in the Future, 1–21. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-68074-9_131-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Glashan, Elizabeth, Theresa Eberhardt, and Sherif Hanafy Mahmoud. "Physical Assessment for Pharmacists." In Patient Assessment in Clinical Pharmacy, 31–53. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Pharmacist and patient":

1

AlMukdad, Sawsan, Nancy Zaglou, Ahmed Awaisu, Nadir Kheir, Ziyad Mahfoud, and Maguy El Hajj. "Exploring the Role of Community Pharmacists in Weight Management in Qatar: A Mixed Methods study." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0154.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Aim: Obesity is a major public health burden in Qatar. Pharmacists can play an important role in providing weight management services (WMS). This study aimed to explore the attitude, practice, perceived competence and role of community pharmacists in obesity and WMS in Qatar. Methods: A mixed-method explanatory sequential design was applied in the study. A validated online questionnaire was used followed by qualitative one-to-one interviews. Quantitative data were analyzed using Statistical Package of Social Sciences Version 24, while qualitative data were analyzed using thematic analysis. Results: Of 600 randomly selected community pharmacists, 270 completed the survey (response rate 45%). More than half of the pharmacists indicated that they often or always explain to patients the risks associated with overweight and obesity (56.2%), recommend weight loss medications, herbs or dietary supplements (52.4%), and counsel about their proper use and/or side effects (56.9%). Conversely, a large proportion of the pharmacists rarely or never measure patients’ waist circumference (83.8%) or calculate their body mass index (72.1%). Over 80% had very positive attitudes towards their role in weight management. Around three-quarters of the participants agreed or strongly agreed that difficulty in following-up with the patient (80.7%), lack of private consultation area (75.7%) and lack of pharmacist time (75.2%) are barriers for implementing WMS. More than 60% stated that they are fully competent in 7 out of 24 WMS related statements. Some emerging include pharmacist’s role and impact in weight management, need for training about weight management, impact of social media on patients’ perceptions, and adoption of best practices for WMS. Conclusion: Qatar pharmacists reported positive attitudes towards provision of WMS. However, they identified several barriers against provision of comprehensive weight management programs. Several strategies are proposed to overcome barriers and to improve provision of WMS in community pharmacies in Qatar.
2

Waei, Ow Mun, Phuah Kit Teng, and Khoong Tai Wai. "Patient Loyalty Towards the Pharmacist." In International Conference on Economics, Business, Social, and Humanities (ICEBSH 2021). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/assehr.k.210805.067.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Blebea, Nicoleta Mirela. "QUALITY ASSURANCE IN PHARMACEUTICAL OPERATIONS." In GEOLINKS Conference Proceedings. Saima Consult Ltd, 2021. http://dx.doi.org/10.32008/geolinks2021/b1/v3/18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The specialized literature does not confer a consensual definition of the quality in the pharmaceutical procedures. Nevertheless, most definitions imply the satisfaction of eth customers’ needs. The customers of the pharmaceutical procedures are the patients and also the professional persons from the domain of health that prescribe, issue and administrate medicines. The pharmacist is a professional person who is in direct contact with the patient, being the first professional person to whom the patients address when the affection is a mild one and they need counselling regarding the medication or diagnostic. The more complex the medication of the patient is, the more probable the side effects shall be. The morbidity and mortality may be consequences at the error of medication. The appearance of some medicines increases directly proportional to the errors of prescribing the medication. The quality in using the medication implies the choice of the medicine, the optimization of the compliance of the patient with the treatment, avoiding side effects, assuring the therapeutical objectives. The possibilities of appearing the errors being numerous, it is easy to understand why the assurance and improvement of the quality of the pharmaceutical procedures are important aspects for pharmacists and patients. The present paper has as purpose the qualitative improvement of the pharmaceutical procedures by the help of the pharmacist, thus the pharmacy becoming a supplier of pharmaceutical care of the best quality
4

Abou-Sido, Marah, Marwa Hamed, Suad Hussen, Monica Zolezzi, and Sowndramalingam Sankaralingam. "Are Blood Pressure Devices Available in Qatar Community Pharmacies Validated For Accuracy?" In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0119.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Research purpose: Hypertension is a leading cause of cardiovascular morbidity and mortality in Qatar. Community pharmacist-managed home blood pressure monitoring (HBPM) services have been shown to provide better control of hypertension. Digital BP devices available and sold in community pharmacies are commonly used for HBPM services. Devices validated for accuracy are important for clinical decision-making. Non-validated devices are more likely to be inaccurate and could potentially lead to poor BP control and health risks. The objectives of our study are 1) to identify the proportion of validated BP devices available in community pharmacies in Qatar and 2) to determine the relationship between the validation status of devices and cuff location and price. Methodology: We visited 28 community pharmacies including the 2 major pharmacy chains in Qatar. The following data were collected about BP devices: brand/model, validation status, cuff location, and price. Findings: A total of 87 distinct models of BP devices from 19 different brands are available in Qatar community pharmacies. The three most commonly available brands are Beurer®, Omron®, and Rossmax®. Most models available are upper arm devices (75%) while the rest are wrist devices (25%). Among all models, only 57.5% are validated. Sixty percent of upper-arm devices and 50% of wrist devices are validated. Importantly, 60% of lower-priced (≤ QAR 250) devices are not validated while 83% of higher-priced (QAR 500-750) devices are validated. Research originality/value: This is a novel study that has investigated the validation status of BP devices available in community pharmacies for the first time. This information will serve both pharmacists and the public alike. In Qatar and elsewhere, there are no regulations on the accuracy of devices sold in community pharmacies. Therefore, regulations on the sale of BP devices should be implemented in the best interest of patient safety.
5

Mohamed, Hiba, Shahd Elamin, Maguy ElHajj, and Alla El-Awaisi. "Understanding COVID-19-related Burnout in Qatar’s Community Pharmacists using the Job Demands-Resources Theory." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0133.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Community pharmacists are one of the most accessible front-liners against the COVID-19 pandemic. Whilst playing a vital role in medication supply and patient education, exposure to pandemic demands and prolonged stressors such as risk of infection increases their risk of burnout. Using the Job Demands-Resources theory, this research aims to identify factors affecting community pharmacists’ COVID-19-related burnout, their coping strategies against it, and recommendations on interventions to mitigate it. This is a qualitative study in which Qatar community pharmacists, with informed consent, took part in semi-structured focus groups/interviews which were recorded, transcribed, and analyzed using inductive/deductive analysis. Twelve themes emerged from six focus groups, six dyadic interviews and mini focus groups, and four individual interviews. The contributing factors to community pharmacist’ burnout were identified as practical job demands, and emotional demands such as fear of infection. However, government and workplace-specific resources, pharmacists’ personal characteristics such as resiliency and optimism, as well as implementation of coping strategies, reduced their stress and burnout. This is the first study to explore the contributing factors to community pharmacists’ COVID-19-related burnout using the job-demands resource model. In turn, individual, organizational, and national recommendations can be made to mitigate burnout in community pharmacists during the pandemic.
6

Abdulrhim, Sara Hamdi, Sownd Sankaralingam, and Mohamed Izham. "The Impact of Pharmacist Care on Diabetes Outcomes in Primary Care Settings: An Umbrella Review of Systematic Reviews." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0174.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Objective: To systematically review published systematic reviews (SRs) examining the impact of pharmacist interventions in multidisciplinary diabetes care teams on diabetes-related clinical, humanistic, and economic outcomes in primary care settings. Methods: PubMed, EMBASE, Scopus, Database of Abstracts of Reviews of Effects, Cochrane Library, Joanna Briggs Institute (JBI) Database, Google Scholar, and PROSPERO were searched from inception to 2018. Studies published in English evaluating the effect of pharmacist interventions on diabetes outcomes were included. Two independent reviewers were involved in the screening of titles and abstracts, selection of studies, and methodological quality assessment. Results: Seven SRs were included in the study. Three of them included only randomized controlled trials, while the rest involved other study designs. Educational interventions by clinical pharmacists within the healthcare team were the most common types of interventions reported across all SRs. Pharmacist’s interventions compared to usual care resulted in favorable significant improvements in hemoglobin A1c (HbA1c), fasting blood glucose, blood pressure, body mass index, total cholesterol, lowdensity lipoprotein, high-density lipoprotein and triglycerides in more than 50% of the SRs. Improvement in HbA1c was the mostly reported clinical outcome of pharmacist intervention in the literature (reported in six SRs). Pharmacist’s interventions led to significant cost-saving ($8–$85,000 per person per year), cost-utility, and cost-benefit (benefit-to-cost ratio range from 1:1 to 8.5:1) versus usual care. Pharmacist’s interventions improved patients’ quality of life (QoL) in three SRs; however, no conclusion can be drawn due to the use of diverse QoL assessment tools. Conclusion: Most SRs support the benefit of pharmacist care on diabetes-related clinical, humanistic, and economic outcomes in primary care settings. Improvements in diabetes outcomes can significantly reduce the burden of diabetes on the healthcare system. Hence, the incorporation of pharmacists into multidisciplinary diabetes care teams is beneficial and should be strongly considered by clinicians and health policymakers.
7

Murphy, D., M. Kieran, and J. Brown. "4CPS-220 Patient satisfaction with pharmacist education on oral anticoagulant medication." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.52.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Crook, JL, J. Ross, D. Devji, and I. Lam. "G46(P) Patient facing pharmacist reduces length of stay for paediatric short stay patients." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference and exhibition, 13–15 May 2019, ICC, Birmingham, Paediatrics: pathways to a brighter future. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-rcpch.46.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Bernard-Arnoux, A., C. Huynh, A. Géry, N. Ranjit, G. Oka, M. Gallard, C. Jacolin, L. Denis, and L. Sadozai. "1ISG-028 Becoming a graduate hospital pharmacist: a French national survey." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sattler, Amelia, Grace Hong, Judith Fitzpatrick, Steven Lin, and marcie levine. "Patient, Physician, and Clinical Pharmacist Experiences Piloting a Remote Patient Monitoring Platform for Diabetes Management." In NAPCRG 50th Annual Meeting — Abstracts of Completed Research 2022. American Academy of Family Physicians, 2023. http://dx.doi.org/10.1370/afm.21.s1.4064.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Pharmacist and patient":

1

Patel, Komal. Assessment of Knowledge, Attitude, Perception of Pharmacy Students Towards Telepharmacy. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/chp.hiim.0072.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Telemedicine is one of the fastest growing area in health care technology and COVID-19 pandemic has changed the way of practicing Telemedicine. Telepharmacy is a part of telemedicine where pharmacy use this technology to provide patient care services. Success of any technology depends on users’ willingness to learn and attitude towards technology. Early assessment of students’ attitude during pharmacy school is important to know in order to assess how receptive students are to accept Telepharmacy in their work setting currently or in future. That will also help to determine success of Telepharmacy implementation. This study will focus on assessing knowledge, attitude and perceptions of student pharmacists towards Telepharmacy.
2

Ciapponi, Agustín. What are the effects of reference pricing and other pharmaceutical pricing and purchasing policies? SUPPORT, 2016. http://dx.doi.org/10.30846/1608143.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Pharmaceutical pricing and purchasing policies are used to determine or affect the prices that are paid for drugs. This review found evidence for reference pricing, index pricing, and maximum prices. In reference pricing a reference drug is chosen amongst identical or similar medicines or therapeutically equivalent and the price of the reference drug is reimbursed for all the drugs in that group of drugs. For drugs that are more expensive than the reference drug, the patient has to pay the cost above the reference price. An index price is the maximum refundable price to pharmacies for drugs within an index group of therapeutically interchangeable drugs. A maximum price is a fixed price that attempts to secure pharmaceutical prices that are considered ‘reasonable’ for a given health system.

До бібліографії